within Pharmacolibrary.Drugs.ATC.L;

model L01EX23
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.365,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.881,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.011111666666666666,
    Tlag           = 10.001999999999999
  );

  annotation(Documentation(
    info ="<html><body><p>Pralsetinib is an orally administered, selective RET receptor tyrosine kinase inhibitor used for the treatment of RET fusion-positive non-small cell lung cancer (NSCLC) and RET-mutant or RET fusion-positive thyroid cancers. It is approved by the FDA and EMA for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients with advanced solid tumors, based on population PK analysis.</p><h4>References</h4><ol><li><p>Wang, Y, et al., &amp; Schinkel, AH (2021). ABCB1 and ABCG2, but not CYP3A4 limit oral availability and brain accumulation of the RET inhibitor pralsetinib. <i>Pharmacological research</i> 172 105850–None. DOI:<a href=&quot;https://doi.org/10.1016/j.phrs.2021.105850&quot;>10.1016/j.phrs.2021.105850</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34450308/&quot;>https://pubmed.ncbi.nlm.nih.gov/34450308</a></p></li><li><p>Suchomel, J, et al., &amp; Cheeti, S (2024). Impact of P-gp inhibition on systemic exposure of pralsetinib and dosing considerations. <i>Clinical and translational science</i> 17(6) e13818–None. DOI:<a href=&quot;https://doi.org/10.1111/cts.13818&quot;>10.1111/cts.13818</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38807449/&quot;>https://pubmed.ncbi.nlm.nih.gov/38807449</a></p></li><li><p>Dolton, MJ, et al., &amp; Chiang, PC (2024). Integrating Dynamic in vitro Systems and Mechanistic Absorption Modeling: Case Study of Pralsetinib. <i>Journal of pharmaceutical sciences</i> 113(9) 2952–2956. DOI:<a href=&quot;https://doi.org/10.1016/j.xphs.2024.07.006&quot;>10.1016/j.xphs.2024.07.006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39002726/&quot;>https://pubmed.ncbi.nlm.nih.gov/39002726</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01EX23;
